FI106984B - Testimenetelmä ja siihen tarkoitettu reagenssipakkaus - Google Patents

Testimenetelmä ja siihen tarkoitettu reagenssipakkaus Download PDF

Info

Publication number
FI106984B
FI106984B FI932912A FI932912A FI106984B FI 106984 B FI106984 B FI 106984B FI 932912 A FI932912 A FI 932912A FI 932912 A FI932912 A FI 932912A FI 106984 B FI106984 B FI 106984B
Authority
FI
Finland
Prior art keywords
gold
analyte
membrane
protein
complex
Prior art date
Application number
FI932912A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI932912A0 (fi
FI932912A (fi
Inventor
Jostein Holtlund
Geir Olav Gogstad
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of FI932912A0 publication Critical patent/FI932912A0/fi
Publication of FI932912A publication Critical patent/FI932912A/fi
Application granted granted Critical
Publication of FI106984B publication Critical patent/FI106984B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
FI932912A 1990-12-24 1993-06-23 Testimenetelmä ja siihen tarkoitettu reagenssipakkaus FI106984B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9028038 1990-12-24
GB909028038A GB9028038D0 (en) 1990-12-24 1990-12-24 Test method and reagent kit therefor
EP9102519 1991-12-21
PCT/EP1991/002519 WO1992011537A1 (en) 1990-12-24 1991-12-21 Test method and reagent kit therefor

Publications (3)

Publication Number Publication Date
FI932912A0 FI932912A0 (fi) 1993-06-23
FI932912A FI932912A (fi) 1993-06-23
FI106984B true FI106984B (fi) 2001-05-15

Family

ID=10687595

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932912A FI106984B (fi) 1990-12-24 1993-06-23 Testimenetelmä ja siihen tarkoitettu reagenssipakkaus

Country Status (15)

Country Link
US (2) US5691207A (da)
EP (1) EP0564494B1 (da)
JP (1) JP3174573B2 (da)
AT (1) ATE115729T1 (da)
AU (1) AU648625B2 (da)
CA (1) CA2093415C (da)
DE (1) DE69106002T2 (da)
DK (1) DK0564494T3 (da)
ES (1) ES2065158T3 (da)
FI (1) FI106984B (da)
GB (1) GB9028038D0 (da)
GR (1) GR3014996T3 (da)
IE (1) IE66474B1 (da)
NO (1) NO311112B1 (da)
WO (1) WO1992011537A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0689454T4 (da) * 1993-03-23 2005-05-30 Smithkline Beecham Biolog Vaccinepræparater indeholdende 3-O-deacyleret monophosphoryl-lipid A
CA2105515A1 (en) * 1993-09-03 1995-03-04 Carlos A. Santizo Lescaille Visual immunoassay method for the detection of ligands, based on the use of opaque plastic supports
JPH08311100A (ja) * 1995-03-13 1996-11-26 Terumo Corp ヒト肺腺癌に関するモノクローナル抗体および抗原、及びそれを用いた免疫測定方法
US5851777A (en) * 1996-02-05 1998-12-22 Dade Behring Inc. Homogeneous sol-sol assay
AU2121497A (en) * 1996-02-22 1997-09-10 Dexall Biomedical Labs, Inc. Non-captive substrate liquid phase immunoassay
US6410692B2 (en) * 1998-02-02 2002-06-25 Novadx, Inc. Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix
US7297554B2 (en) * 1998-11-18 2007-11-20 Microdiagnostics, Inc. Immunoassay system
FR2810739B1 (fr) * 2000-06-26 2007-01-26 Centre Nat Rech Scient Immunodosage electrochimiques a l'aide de marqueurs metalliques colloidaux
DE10141691A1 (de) * 2001-08-25 2003-03-13 Friz Biochem Gmbh Verdrängungsassay zur Detektion von Ligat-Ligand-Assoziationsereignissen
AU2003212471A1 (en) * 2002-02-27 2003-09-09 Miragene, Inc. Improved substrate chemistry for protein immobilization on a rigid support
DE10211818B4 (de) * 2002-03-16 2006-07-06 peS Gesellschaft für medizinische Diagnose-Systeme mbH Verfahren zur quantitativen Bestimmung mehrerer Analyten
US6824776B2 (en) * 2003-04-16 2004-11-30 The United States Of America As Represented By The Secretary Of The Navy Silica mesoporous aerogels having three-dimensional nanoarchitecture with colloidal gold-protein superstructures nanoglued therein
WO2005111619A1 (en) * 2004-04-29 2005-11-24 Marc Ramael Method and kit for detecting components in a sample
US7871781B2 (en) * 2005-05-23 2011-01-18 Phadia Ab Two step lateral flow assay methods and devices
ITUD20060177A1 (it) 2006-07-14 2008-01-15 Sire Analytical Systems Srl Apparecchiatura integrata e metodo per la rilevazione di stati infiammatori presenti in un campione di sangue intero
US20100136517A1 (en) * 2007-05-07 2010-06-03 Massachusetts Institute Of Technology Matrix stabilization of aggregation-based assays
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
US10527628B2 (en) 2015-05-01 2020-01-07 Diagnostear, Ltd. Method for measuring tear constituents in a tear sample
CN109068971A (zh) * 2016-01-14 2018-12-21 黛尔格诺斯蒂尔有限公司 测定泪液样品中的泪液成分的方法
CN112578109B (zh) * 2020-12-08 2022-10-11 广东海洋大学深圳研究院 定性定量检测试剂、制备方法及定性定量检测试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853987A (en) * 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
NL7807532A (nl) * 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
GB2045431B (en) * 1979-02-26 1983-04-20 Technicon Instr Immunoassay utilising two particulate reagents
US4434150A (en) * 1981-10-19 1984-02-28 Ortho Diagnostic Systems, Inc. Immunological reagents employing polymeric backbone possessing reactive functional groups
US4880751A (en) * 1986-10-31 1989-11-14 Board Of Regents, The University Of Texas System Immunoglobulin adsorption
US4859612A (en) * 1987-10-07 1989-08-22 Hygeia Sciences, Inc. Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
ES2039025T3 (es) * 1987-11-16 1993-08-16 Janssen Pharmaceutica N.V. Un agregado para determinar sustancias combinables.
GB8800702D0 (en) * 1988-01-13 1988-02-10 Nycomed As Test method & reagent kit therefor
AU7688191A (en) * 1990-03-28 1991-10-21 Board Of Regents, The University Of Texas System Production of electrophoretically-uniform protein-colloidal gold complexes

Also Published As

Publication number Publication date
WO1992011537A1 (en) 1992-07-09
ATE115729T1 (de) 1994-12-15
ES2065158T3 (es) 1995-02-01
NO932320L (no) 1993-06-23
US5650333A (en) 1997-07-22
NO311112B1 (no) 2001-10-08
EP0564494A1 (en) 1993-10-13
CA2093415C (en) 2003-02-25
IE914536A1 (en) 1992-07-01
FI932912A0 (fi) 1993-06-23
DK0564494T3 (da) 1995-03-06
JP3174573B2 (ja) 2001-06-11
FI932912A (fi) 1993-06-23
DE69106002D1 (de) 1995-01-26
US5691207A (en) 1997-11-25
JPH06503886A (ja) 1994-04-28
EP0564494B1 (en) 1994-12-14
GR3014996T3 (en) 1995-05-31
CA2093415A1 (en) 1992-06-25
GB9028038D0 (en) 1991-02-13
IE66474B1 (en) 1995-12-27
NO932320D0 (no) 1993-06-23
AU648625B2 (en) 1994-04-28
DE69106002T2 (de) 1995-05-11
AU9093491A (en) 1992-07-22

Similar Documents

Publication Publication Date Title
FI92883C (fi) Testimenetelmä ja reagenssikitti sitä varten
FI106984B (fi) Testimenetelmä ja siihen tarkoitettu reagenssipakkaus
RU2025732C1 (ru) Способ иммуноанализа аналита в водном образце
JP2651060B2 (ja) 同時較正不均質イムノアツセイ用装置
JP2002521693A (ja) 水溶性架橋結合体の製造方法
CA2164939A1 (en) Rapid detection of analytes with receptors immobilized on soluble submicron particles
CA2133967A1 (en) Immobilization of specific binding assay reagents
FR2890173A1 (fr) Dispositif de determination d'un analyte dans un echantillon liquide par un test sandwich et un test de competition
US5405752A (en) Enzyme conjugate prepared with insoluble nonoparticle
JP3484540B2 (ja) 可溶性サブミクロン粒子上に固定化した抗体による抗原の無作為検出
US20160341723A1 (en) Au nanoparticles encapsulated in nanocompoites and applications thereof in rapid detection of an analyte
US20100173425A1 (en) High Capacity Solid Phase
JPH1068730A (ja) イムノクロマト法用試験用具
CN113125705B (zh) 一种肌红蛋白的均相检测试剂盒及其应用
CN113125703B (zh) 一种肌红蛋白的均相检测试剂盒及其应用
CA2104596A1 (en) Multi-test immunochemical reagent and method to use same
JPH0348766A (ja) 免疫学的測定法
JP3727661B6 (ja) シグナル発生酵素としてバナジウムブロモペルオキシダーゼを使った特異的結合リガンドの測定用の分析要素および方法
EP0184701A2 (en) A method for determining a ligand
MXPA98004040A (en) A particle resistant to storage, in particular a carrier for united reactions to carrier and the processes for the production of the